Raza M. Shah MDVitreo-Retinal Specialist, Maryland Retina Institute, Olney, Maryland
Raza M. Shah, MD is board certified by the American Board of Ophthalmology (ABO) as well as subspecialty trained by an Association of University Professors of Ophthalmology (AUPO) accredited fellowship. He specializes in diseases of the retina, macula, and vitreous. A Pennsylvania native, Dr. Shah attended college at West Chester University of Pennsylvania. He later earned his medical degree at Drexel University College of Medicine and remained there to pursue his residency in Ophthalmology where he was also honored to serve as Chief Resident. Dr. Shah then pursued his fellowship training in vitreoretinal surgery at the Associated Retina Consultants in Phoenix, Arizona.
Dr. Shah has been privileged to author or co-author over 40 book chapters and topics as well as publish scientific articles in peer-reviewed journals. He has been invited to lecture both physicians and students on current clinical issues. As a resident, he received multiple honors including Intern of the Year, Resident of the Year, and the Golden Apple for Teaching by the College of Medicine. He was even bestowed with Hahnemann University Hospital’s highest award for training physicians – “Excellence in Clinical Practice for a Fellow, Resident, or Intern.” Dr. Shah enjoys all aspects of retinal disease, but has particular interests in the management of acute, subacute, and chronic retinal disorders including age-related macular degeneration, diabetic retinopathy, and complex retinal detachments. Dr. Shah is a member of the American Society of Retinal Specialists and the American Academy of Ophthalmology.
Recent Contributions to PracticeUpdate:
- Risk for Intraocular Bleeding With Novel Oral Anticoagulants
- Multimodal Imaging and Vision Testing in Macular Dengeneration
- Choroidal Thickness Change After Intravitreal Aflibercept for Macular Degeneration
- Choroidal Thickness Changes Following Intravitreal Dexamethasone Implant Injection in Retinal Vein Occlusion
- Delayed Injection of Ranibizumab Worsens Visual Prognosis in AMD
- Aqueous Humour Concentrations of VEGF and PEDF With Ranibizumab for Myopic Choroidal Neovascularization
- Determining the Optimal Imaging Strategy for Neovascular Age-Related Macular Degeneration
- Therapies for Macular Edema Associated With Central Retinal Vein Occlusion
- Geographic Atrophy in Neovascular AMD After Anti-VEGF Injection
- Medicare Beneficiaries With Disorders of Binocular Vision at Risk for Musculoskeletal Injuries, Fractures, and Falls